Introduction: Viscosupplementation by intraarticular injection of hyaluronic acid (HA) is a widely used treatment for lower limb osteoarthritis. However, the injected HA is rapidly degraded by reactive oxygen species (ROS), limiting its time of intra-articular residence. Optimizing clinical effectiveness of viscosupplementation by reducing HA degradation in situ, and therefore increasing the time of contact with the diseased tissue, is a challenging research approach. Mannitol, a
. These discrepancies may originate from differences in efficacy between the studied products, varying in concentration, MW, and molecular crosslinkage [20] . Indeed, the HA injected into the joint is rapidly degraded, limiting the time of intra-articular residence from a few days for linear molecules [17] to a few weeks for the solutions of cross-linked HA [18, 19] . Among the many pathogenic mechanisms contributing to HA degradation, reactive oxygen species (ROS) derivatives play a major role [31, 32] . Then OA is a degenerative joint disease of multifactorial origin in the pathogenesis of which ROS play a deleterious effect [33] . It has been shown that interleukin-1b (IL-1b) activates the production by the chondrocytes of large amounts of ROS which are themselves involved in the production and/or the activation of collagenase matrix metalloproteinase-1 and in the phenomena of chondrocyte apoptosis [34] .
In addition to their effect on the degradation of the ECM, ROS are directly involved in the mechanisms of degradation of HA. Optimizing clinical effectiveness of viscosupplementation by reducing HA degradation in situ, and therefore increasing the time of contact with the diseased tissue [35] , is a challenging research approach. We [36] and others [32] have previously shown that the addition of mannitol (a polyol well known for its ROSscavenging properties) with HA, protects the latter to ROS-mediated degradation and therefore may increase the injected HA residence time into the joint.
The aim of the present study was to compare in vitro the resistance to ROS-mediateddegradation of two marketed viscosupplements (one linear and one cross-linked) to that of two novel viscosupplements combining HA and mannitol.
METHODS
This article does not contain any studies with human or animal subjects performed by any of the authors. 
Viscosupplements to be Assessed

Induction of Oxidative Stress
Hydrogen peroxide (H 2 O 2 ) application is a wellknown method to degrade polysaccharides through a radical mechanism [37] . The 4 HA viscosupplements mentioned above were subjected to oxidative stress generated by the addition of H 2 O 2 (30%; Carl Roth GmbH & Co.
KG, Lauterbourg, Germany) at a final concentration of 2.7% and/or 5.4% (v/v). For that purpose, the commercial samples were added of H 2 O 2 in a ratio 10:1 and stirred before being placed rapidly on the rheometer (delay time between addition of H 2 O 2 and first measurement was 2 min).
Rheological Assessment
The rheological properties were measured using a cone-plate rheometer (ARES-G2 Rheometer; TA Under the same experimental conditions, the kinetics of degradation of the two crosslinked viscosupplements was compared (see Figs. 3, 4) . The influence of mannitol is again obvious. Nevertheless, the level of the elastic modulus (G 0 ) of HANOX-M-XL, which is much higher than that of Hylan G-F 20, indicates that its degree of cross-linkage is higher than that of Hylan G-F 20. The better resistance to degradation of HANOX-M-XL is likely due to both mannitol and its high level of crosslinkage. Figure 4 represents the rheological parameters after 15 min of oxidative degradation. properties as a ROS scavenger. The beneficial effect related to its antioxidant power towards the rich reactive hydroxyl function has been shown in various diseases [38] [39] [40] [41] .
In viscosupplementation, the rationale of its combination with HA is legitimate: When administered intra-articularly, HA macromolecules of the viscosupplement, containing many OH groups, react with ROS, resulting in the rupture of the macromolecular chains and accelerated degradation by radical mechanism [31] . This rapid depolymerization of HA is the main cause for the short intra-articular half-life of viscosupplements made of non-crosslinked HA, cross-linking being another way to protect HA from degradation by ROS [18, 19] . The chemical characteristics of mannitol make it an antioxidant of choice in combination with HA.
As with HA, mannitol has a very good safety profile, as demonstrated by animal tests showing that it was non-cytotoxic, non-genotoxic, noncarcinogenic, and non-mutagenic, even at high doses [42] . In humans, mannitol is widely used per os and by intravenous injection at very high concentrations, including hyperosmolar concentrations [43] . Its resistance to heat also permits sterilization by autoclaving, unlike other antioxidants that are thermolabile (e.g., polyphenols, vitamin C). Furthermore, mannitol does not increase the ionic strength of the medium and thus does not significantly alter the rheological behavior of the HA, and is hydrosoluble, unlike antioxidants such as vitamin E or betacarotene [44] . Two open-label clinical trials assessing viscosupplements containing antioxidants (mannitol 5 g/L [45] or its isomer sorbitol 40 g/L [46] ) in patients suffering from knee OA have been recently published. In both, safety was similar to that of conventional viscosupplements not containing antioxidant, and none of them has revealed any serious or unexpected adverse effects. In the absence of a control group, the efficacy cannot be conclusively assessed; however, the published results strongly suggested the beneficial effects of the treatments on pain and function.
Our data also suggested that HA crosslinking, high MW and high concentration may play a role in the improved resistance to oxidative stress and are other effective ways to protect HA from degradation.
CONCLUSION
In summary, this in vitro study demonstrates that mixing high concentrations of mannitol with HA, protects the viscosupplement from ROS-mediated degradation and might therefore increase the intra-articular residence time of the gel without substantially modifying its rheological behavior. Thereby, the combination of HA and mannitol might be a simple mean to improve the efficiency and/or the duration of action of joint viscosupplementation. These in vitro results fully justify the in vivo studies already in progress with both HANOX-M and HANOX-M-XL whose aims are to confirm or refute this exciting hypothesis and to assess the effectiveness and safety of this new promising association on large samples of patients.
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